PATENT CLAIM ANALYSIS

Application Number: 16038968
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-02
Patent Classification: ["514", "252120"]

Abstract:
(−)-Jorumycin, ecteinascidin 743, saframycin A and related compounds, methods of preparing the same, formulations comprising the compounds, and methods of treating proliferative diseases with the same are provided.

Claim (Index 7):
The method of  claim 6 , wherein the iridium catalyst is prepared by combining an iridium source and a chiral ligand.

Metadata:
- Claim Count in Document: 28.0
- Percentile: 95.0
- Lexical Diversity: 1.42308
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15366590', '14972475', '14514001', '15081157', '14960799']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8455106555341765
- 35 USC 102 Novelty (BERT): 0.5620005778562023
- Combined Prediction Score: 0.8171596477663791
- Mean Citation Score: 493.983978
- Max Citation Score: 515.08453
- Similarity Product: 312.4543522620058

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test